Pheton Holdings Ltd

Pheton Holdings Ltd (PTHL) Stock Analysis

$0.902

+0.949 (+105.16%)At close

Loading chart…
High
1.090
Open
0.423
VWAP
0.79
Vol
74.89M
Mkt Cap
—
Low
0.391
Amount
59.49M
EV/EBITDA, TTM
0.00

iTonic Holdings Ltd, formerly Pheton Holdings Ltd, is a holding company principally engaged in the provision of healthcare solutions through its subsidiary Beijing Feitian Zhaoye Technology Co., Ltd. (Beijing Feitian). The Company’s main businesses include development and commercialization of brachytherapy treatment planning system (TPS) specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. TPS is generally a computer software used in different types of radiotherapy. The Company’s main product is FTTPS, a user-oriented TPS for treating a wide variety of malignant tumors. Beijing Feitian’s product portfolio also includes Medical Auxiliary Supplies such as seed implant needles, computer workstations, patient positioning device and others.

Valuation Metrics

The current forward P/E ratio for Pheton Holdings Ltd (PTHL) is 0.00, compared to its 5-year average forward P/E of 0.00.

Forward P/E

Strongly Undervalued
5Y Average P/E
0.00
Current P/E
0.00
Overvalued
0.00
Undervalued
0.00

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued
0.00
Undervalued
0.00

Forward P/S

Strongly Undervalued
5Y Average P/S
0.00
Current P/S
0.00
Overvalued
0.00
Undervalued
0.00

Alphio AI Price Scenarios for PTHL

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%PTHL

$24.92

Scenario price

B

Base

Base · 50%PTHL

$24.10

Scenario price

B

Bear

Bear · 25%PTHL

$23.19

Scenario price

Events Timeline

2026-01-13 (ET)

08:50:00

Pheton Holdings Renames to iTonic Holdings, Changes Ticker to ITOC

2025-10-23 (ET)

16:44:05

Pheton Holdings Notified of Noncompliance by Nasdaq

2025-08-01 (ET)

09:30:52

Pheton denies any involvement in 'any form of stock price manipulation'

Show More Events

News

Show More News

PTHL FAQ — answered by Alphio AI

iTonic Holdings Ltd, formerly Pheton Holdings Ltd, is a holding company principally engaged in the provision of healthcare solutions through its subsidiary Beijing Feitian Zhaoye Technology Co., Ltd. (Beijing Feitian). The Company’s main businesses include development and commercialization of brachytherapy treatment planning system (TPS) specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. TPS is generally a computer software used in different types of radiotherapy. The Company’s main product is FTTPS, a user-oriented TPS for treating a wide variety of malignant tumors. Beijing Feitian’s product portfolio also includes Medical Auxiliary Supplies such as seed implant needles, computer workstations, patient positioning device and others. It operates in the Healthcare sector.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started